Lakeside

Runs a China-based pharmaceutical-distribution business through Hupan Pharmaceutical, sourcing infusion products, specialty prescription drugs, and medical-nutrition products from manufacturers. Products are stored in designated warehouses and sold and delivered, primarily through agents, to distributors, hospitals, clinics, and other healthcare providers.

Became the sole disclosed revenue-producing continuing operation after the former U.S. cross-border logistics business was transferred. Operations depend on access to manufacturers, agents, healthcare customers, Chinese pharmaceutical demand, and a specialized pharmaceutical-distribution license; the parent reports in U.S. dollars while the operating business uses renminbi. The current Nasdaq name and ticker change are not accompanied in opened primary sources by a documented product or operating strategy.